Publications

Authors:

Giordano, Guido; Febbraro, Antonio; Tomaselli, Eugenio; Sarnicola, Maria Lucia; Parcesepe, Pietro; Parente, Domenico; Forte, Nicola; Fabozzi, Alessio; Remo, Andrea; Bonetti, Andrea; Manfrin, Erminia; Ghasemi, Somayehsadat; Ceccarelli, Michele; Cerulo, Luigi; Bazzoni, Flavia; Pancione, Massimo

Title:

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

Year:

2015

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Format:

A Stampa

Referee:

Sì

Name of journal:

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

ISSN of journal:

1756-9966

N° Volume:

34

Number or Folder:

1

Page numbers:

108-118

Keyword:

ERBB3 or FGFR4; CD15/FUT4; EGFR or VEGF; Metastatic CRC

Short description of contents:

Cancer-related immune antigens in the tumor microenvironment could represent an obstacle to agents targeting EGFR "cetuximab" or VEGF "bevacizumab" in metastatic colorectal cancer (mCRC) patients.

Web page:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590269/pdf/13046_2015_Article_225.pdf

Product ID:

88493

Handle IRIS:

11562/928277

Last Modified:

November 8, 2022

Bibliographic citation:

Giordano, Guido; Febbraro, Antonio; Tomaselli, Eugenio; Sarnicola, Maria Lucia; Parcesepe, Pietro; Parente, Domenico; Forte, Nicola; Fabozzi, Alessio; Remo, Andrea; Bonetti, Andrea; Manfrin, Erminia; Ghasemi, Somayehsadat; Ceccarelli, Michele; Cerulo, Luigi; Bazzoni, Flavia; Pancione, Massimo, Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH» , vol. 34 , n. 1 , 2015 , pp. 108-118

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo